3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
11
Myelodysplastic Syndromes
5
Myeloproliferative Disorders
3
Advanced Solid Tumour
3
Small Cell Lung Carcinoma
2
Recurrence
2
Leukemia, Myelomonocytic, Chronic
2
Esophageal Squamous Cell Carcinoma
2
Carcinoma, Non-Small-Cell Lung
2
Ovarian Neoplasms
1
Non-Muscle Invasive Bladder Neoplasms
1
Neuroma
1
Neoplasms
1
Neoplasm Metastasis
1
Multiple Sclerosis
1
Multiple Myeloma
1
Lung Neoplasms
1
Leukemia, Myeloid, Accelerated Phase
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Idiopathic Pulmonary Fibrosis
1
Esophageal Neoplasms
1
Depression
1
Colorectal Neoplasms
1
Carcinoma, Hepatocellular
1
Blast Crisis
1
Anxiety Disorders
1
Amyotrophic Lateral Sclerosis
1
Advanced Malignant Solid Tumors
1
Advanced Lung Cancer
1
Advanced Breast Cancer
1
Interventions
Oxaliplatin
3
Leucovorin
3
Fluorouracil
3
Capecitabine
3
zolbetuximab
2
trastuzumab deruxtecan
2
pembrolizumab
2
Ramucirumab
2
Paclitaxel
2
repotrectinib
1
lenvatinib
1
fludarabine
1
enzalutamide
1
durvalumab
1
darolutamide
1
aldesleukin
1
Vinorelbine
1
Radiosurgery
1
Radiation
1
Prednisone
1
Prednisolone
1
Pemetrexed
1
PF06821497
1
Nivolumab
1
Negative-Pressure Wound Therapy
1
Microscopy, Confocal
1
MORAb-202
1
Irinotecan
1
Immunotherapy
1
Etoposide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Adenocarcinoma
×
Injections
×
30 days
×
Clear all
No trials found.